“Efficacity of Gefitinib or Erlotinib for EGFR- Mutant Advanced Non-Small Cell Lung Carcinoma”. 2022. Latakia University Journal -Medical Sciences Series 43 (6): 25-32. https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11534.